Enhanced Nitric Oxide (NO) and Decreased ADMA Synthesis in Pediatric ADHD and Selective Potentiation of NO Synthesis by Methylphenidate

Enhanced Nitric Oxide (NO) and Decreased ADMA Synthesis in Pediatric ADHD and Selective Potentiation of NO Synthesis by Methylphenidate

Attention deficit hyperactivity disorder (ADHD) is a common pediatric psychiatric disorder, frequently treated with methylphenidate (MPH). Recently, MPH’s cardiovascular safety has been questioned by observational studies describing an increased cardiovascular risk in adults and blood pres...

Full description

Bibliographic Details
Main Authors: Kathrin Jansen, Beatrice Hanusch, Saskia Pross, Erik Hanff, Kathrin Drabert, Alexander Bollenbach, Irina Dugave, Christina Carmann, Rainer Georg Siefen, Barbara Emons, Georg Juckel, Tanja Legenbauer, Dimitrios Tsikas, Thomas Lücke
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Journal of Clinical Medicine
Subjects:
l-arg/no pathway
cardiovascular risk
psychiatric disorder
pharmacotherapy
blood pressure regulation
Online Access:https://www.mdpi.com/2077-0383/9/1/175

Internet

https://www.mdpi.com/2077-0383/9/1/175

Similar Items